GLP-1T

Tirzepatide is a synthetic dual-agonist peptide studied for its binding activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is used in receptor-binding, incretin-pathway, and metabolic research settings.
Studied for (preclinical / in vitro research):
• Dual GIP/GLP-1 receptor agonism in receptor-binding assays
• Incretin hormone signaling pathways in animal models
• Pancreatic beta-cell insulin secretion pathways in vitro
• Gastric emptying rate and GI motility mechanisms in animal models
• Downstream receptor signaling (cAMP/PKA pathway) in cell culture
• Pharmacokinetic and receptor-affinity characterization

For Laboratory Research Use Only. Not for human or veterinary use. Not a drug, dietary supplement, or cosmetic. Not intended to diagnose, treat, cure, or prevent any disease. Not for in-vivo use of any kind outside of a controlled research setting. Keep out of reach of children. By purchasing, you certify that you are a qualified researcher or research institution acquiring this product solely for in vitro laboratory research, and that you accept sole responsibility for compliance with all applicable local, state, and federal laws and regulations.